STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Story continues below

Exhibits.

Exhibit No.

Description

10.1

Employment Agreement Between the Company and Matthew Hill Effective as of May 15, 2018


STRATA Skin Sciences, Inc. Exhibit
EX-10.1 2 ex_10-1.htm CFO EMPLOYMENT AGREEMENT DATED 5-15-18   EXHIBIT 10.1       EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT,…
To view the full exhibit click here

About STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN)

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Recent Trading Information

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) closed its last trading session down -0.07 at 1.71 with shares trading hands.

An ad to help with our costs